Marksans Pharma equity shareholders approves Scheme of Amalgamation of Mark Remedies

Marksans Pharma Ltd has announced that the equity shareholders of the Company at their, Court Convened Meeting held on September 28, 2006, have approved the Scheme of Amalgamation of Mark Remedies Ltd with the Company, with requisite majority.

Source : Equity Bulls

Keywords